Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CanzX Biotherapeutics
Shoreline, Washington, United States
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
CanZx Biotherapeutics (operating as CanCure, LLC) is a biotechnology company focused on developing a new generation of cancer immunotherapies. The company's lead asset, CuraB-10 (also known as CB-10 or SYB-010), is a first-in-class monoclonal antibody designed to target soluble MIC (sMIC), a ligand that tumors shed to evade the immune system. By neutralizing sMIC and stabilizing tumor-bound MIC, CanZx aims to restore the innate and adaptive immune response against various solid tumors, including prostate cancer and melanoma. The company has established strategic partnerships with Samyang Biopharm and CHA Biotech to advance its pipeline and explore combination therapies. Beyond oncology, CanZx is exploring the application of its technology in infectious and autoimmune diseases.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyAntibody
- Industry
- Biotech
02
Partnerships
Samyang BiopharmCHA Biotech
Beyond the preview
Go deeper on CanzX Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CanzX Biotherapeutics.